Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05205551 · ClinicalTrials.gov registry record
Prospera Test Evaluation in Cardiac Transplant (ProTECT)
A clinical trial of Heart Transplant Rejection, sponsored by Natera.
- Active
- Registry status
- 411
- Enrollment target
- 1
- Study location
NCT05205551 is a study of Heart Transplant Rejection that is active but no longer recruiting, run by Natera. The registered enrollment target is 411 participants, below the 659-participant average among 5 other Heart Transplant Rejection trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05205551, a study of Heart Transplant Rejection, is active but no longer recruiting, sponsored by Natera.
- ACTIVE NOT RECRUITING
- Registry status
- 411 participants
- Enrollment target
- 1
- Study location
Study Summary
The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care, who are enrolled within 60 days of heart transplantation.
Conditions Studied
Study Locations (1)
California
- Natera - San Carlos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2021-10-01 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05205551
The ClinicalTrials.gov registry entry for NCT05205551 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 411 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 659-participant average among 5 other Heart Transplant Rejection trials with a reported enrollment target (38% lower). The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Transplant Rejection appearing as the primary indexed condition, and to 0 interventions.
NCT05205551 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05205551 about?
NCT05205551 is a clinical study titled "Prospera Test Evaluation in Cardiac Transplant (ProTECT)". The ProTECT registry is an observational longitudinal, multi-center study observing patients undergoing heart transplant for whom Prospera testing is part of routine clinical care, who are enrolled within 60 days of heart transplantation.
What is the current status of trial NCT05205551?
This trial is currently active not recruiting. The enrollment target is 411 participants. The study started on 2021-10-01. Estimated completion is 2027-06-30.
What conditions does trial NCT05205551 study?
This clinical trial studies the following conditions: Heart Transplant Rejection.
Who is sponsoring clinical trial NCT05205551?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05205551 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplant Rejection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
RECRUITING · NA
-
Trifecta-Heart cfDNA-MMDx Study
RECRUITING
-
Surveillance HeartCare® Outcomes Registry
ACTIVE NOT RECRUITING
-
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
COMPLETED · Phase 2
-
The TOGETHER Project - Heart
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.